Pembrolizumab vs Rosiglitazone

## Pembrolizumab vs Rosiglitazone: Overview

This comparison examines the pharmacological differences between **Pembrolizumab** and **Rosiglitazone**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Pembrolizumab — 26 days; Rosiglitazone — N/A.

## Chemical Properties

**Type**: Pembrolizumab — Antibody; Rosiglitazone — Small molecule.